Otolaryngological manifestations of leishmaniosis

Travel to developing countries is associated with possibility to acquire different, also parasitic, diseases which have become a diagnostic and therapeutic problem. The ENT specialist is one of the medical officers who may make initial contact with a patient with a suspected parasitic disease. One of them is leishmaniosis: a parasitic disease classified as Neglected Tropical Diseases (NTD), which occurs in the tropics, subtropics and southern Europe. While asymptomatic invasion is observed in some cases, three forms of symptomatic leishmaniosis can be distinguished: cutaneous leishmaniosis (CL), visceral leishmaniosis (VL), and mucosal leishmaniosis (ML). Signs and symptoms of these forms, as well as the differential diagnosis, diagnostic procedures and treatment are presented in the paper

Objawy otolaryngologiczne w leiszmaniozie

Podróże do krajów rozwijających się związane są z niebezpieczeństwem zarażenia różnymi chorobami, w tym pasożytniczymi. Schorzenia te stają się istotnym problemem diagnostycznym i terapeutycznym. Biorąc pod uwagę towarzyszące im objawy, laryngolog może być specjalistą, który jako pierwszy przystąpi do ich diagnostyki. Jedną z tych chorób może być leiszmanioza, klasyfikowana jako jedna z Tropikalnych Chorób Zaniedbanych (NTD – Neglected Tropical Disease) i występująca w strefie klimatu tropikalnego, subtropikalnego oraz Europie Południowej. W części przypadków jej przebieg jest bezobjawowy, natomiast w objawowej leiszmaniozie wyróżnia się trzy postacie: skórną (CL), trzewną (VL) i śluzówkową (ML). W pracy opisano objawy podmiotowe i przedmiotowe, różnicowanie, diagnostykę oraz leczenie poszczególnych postaci leiszmaniozy

Otolaryngological manifestations of leishmaniosis

Travel to developing countries is associated with possibility to acquire different, also parasitic, diseases which have become a diagnostic and therapeutic problem. The ENT specialist is one of the medical officers who may make initial contact with a patient with a suspected parasitic disease. One of them is leishmaniosis: a parasitic disease classified as Neglected Tropical Diseases (NTD), which occurs in the tropics, subtropics and southern Europe. While asymptomatic invasion is observed in some cases, three forms of symptomatic leishmaniosis can be distinguished: cutaneous leishmaniosis (CL), visceral leishmaniosis (VL), and mucosal leishmaniosis (ML). Signs and symptoms of these forms, as well as the differential diagnosis, diagnostic procedures and treatment are presented in the paper

The in vitro activity of selected mouthrinses on standard strains of fungi

An oral cavity hygiene plays a key role in prophylactic and therapeutic measures to prevent pathological changes caused by different viruses, bacteria, fungi and protozoa. It is important to maintain proper oral hygiene and assist the removal of potent pathogens; use of the mouthrinses can be one of method providing to these goal. The purpose of this study was to investigate the effects of selected mouthrinses on the standard strains of Candida presented in the oral cavity. Eight reference strains of fungi were investigated: C. albicans (CBS 2312), C. albicans (L 45), C. albicans (ATCC 24433), C. dubliniensis (CBS 7987), C. glabrata (CBS 862), C. krusei (CBS 573), C. parapsilosis (CBS 10947) and C. tropicalis (CBS 2424). Thirteen mouthrinses were used in the study, including pure chlorhexidine (CHX), and 12 commercially available varieties: Azulan, Colgate Plax Complete Care Sensitive, Corsodyl 0,2%, Curasept ADS 205, Dentosept, Dentosept A, Eludril Classic, Listerine Total care, Octenidol, Oral-B Pro-Expert Clinic Line, Sylveco and Tinctura salviae. The present study used a qualitative diffusion in agar gel-well plate method to evaluated the antifungal properties of mouthrinses. Among the 12 commercially available mouthrinses examined in the study, the following were not found to show antifungal activity: Azulan, Dentosept, Eludril Classic, Listerine Total care, Tinctura salviae. The largest inhibition zones were produced by Dentosept, Chlorhexidine and Colgate. The smallest inhibition zones were produced by Octenidol and Curasept. With regard to mouthwash type, statistically significant differences in growth inhibition zone diameter were found between the following pairs of fungi: C. albicans and C. krusei for Colgate without dilution and with 1:2 dilution; C. albicans and C. glabrata for Corsodryl without dilution and with 1:2 dilution; C. albicans and C. dubliniensis for Dentosept A without dilution; C. glabrata and C. parapsilosis with 1:2 dilution; C. dubliniensis and C. tropicalis for Sylveco without dilution, 1:2 dilution and 1:4 dilution; C. dubliniensis and C. parapsilosis for Sylveco without dilution, 1:2 dilution and 1:4 dilution. The lowest MIC values calculated from the Iinear regression equation, indicating the strongest potential activity, were obtained for Dentosept A, followed by chlorhexidine; the lowest activity, was calculated for Curasept and for Octenidol. Some of the tested mouthrinses have antimycotic properties at commercially available concentrations. In spite of the fact that chlorhexidine is thought to be the gold standard for mouthrinse use, Dentosept has stronger antimycotic activity and acts on a wider spectrum of fungi species. Chlorhexidine and Colgate do not appear to act against C. tropicalis, neither does Curaspet against C.dubliniensis; therefore, the determination of the fungus species is necessary